These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Distinguishing features between valproate-induced tremor and essential tremor. Alonso-Juarez M; Baizabal-Carvallo JF Acta Neurol Scand; 2018 Aug; 138(2):177-181. PubMed ID: 29749618 [TBL] [Abstract][Full Text] [Related]
5. Clinical and surface EMG characteristics of valproate induced tremors. Mehndiratta MM; Satyawani M; Gupta S; Khwaja GA Electromyogr Clin Neurophysiol; 2005; 45(3):177-82. PubMed ID: 15981690 [TBL] [Abstract][Full Text] [Related]
6. Tremor Distribution and the Variable Clinical Presentation of Essential Tremor. Bologna M; Berardelli I; Paparella G; Ferrazzano G; Angelini L; Giustini P; Alunni-Fegatelli D; Berardelli A Cerebellum; 2019 Oct; 18(5):866-872. PubMed ID: 31422549 [TBL] [Abstract][Full Text] [Related]
7. Computerized tremor analysis of valproate-induced tremor: a comparative study of controlled-release versus conventional valproate. Rinnerthaler M; Luef G; Mueller J; Seppi K; Wissel J; Trinka E; Bauer G; Poewe W Epilepsia; 2005 Feb; 46(2):320-3. PubMed ID: 15679514 [TBL] [Abstract][Full Text] [Related]
8. Sodium valproate induced tremor in a patient with epilepsy and Down's syndrome. Siniscalchi A; Gallelli L; Loizzo S; Tiziana A; Russo E; De Sarro G Curr Drug Saf; 2013 Feb; 8(1):69-71. PubMed ID: 23656451 [TBL] [Abstract][Full Text] [Related]
9. The clinical characteristics and related factors of tremor in patients with epilepsy. Xiao Y; Xiong W; Lu L; Chen J; Zhang Y; Jiang X; Zhou D Seizure; 2019 Mar; 66():70-75. PubMed ID: 30807902 [TBL] [Abstract][Full Text] [Related]
10. Tremor and Movement Slowness Are Two Unrelated Adverse Effects Induced by Valproate Intake. De Biase A; Paparella G; Angelini L; Cannavacciuolo A; Colella D; Cerulli Irelli E; Giallonardo AT; Di Bonaventura C; Berardelli A; Bologna M Mov Disord Clin Pract; 2022 Nov; 9(8):1062-1073. PubMed ID: 36339307 [TBL] [Abstract][Full Text] [Related]
11. Essential tremor and cerebellar dysfunction clinical and kinematic analysis of intention tremor. Deuschl G; Wenzelburger R; Löffler K; Raethjen J; Stolze H Brain; 2000 Aug; 123 ( Pt 8)():1568-80. PubMed ID: 10908187 [TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of motor performance in epilepsy patients treated with valproate. Farkas Z; Gulyás S; Molnár R; Szirmai I; Kamondi A Seizure; 2010 Apr; 19(3):173-7. PubMed ID: 20167509 [TBL] [Abstract][Full Text] [Related]
13. Distribution of tremor among the major degrees of freedom of the upper limb in subjects with Essential Tremor. Pigg AC; Thompson-Westra J; Mente K; Maurer CW; Haubenberger D; Hallett M; Charles SK Clin Neurophysiol; 2020 Nov; 131(11):2700-2712. PubMed ID: 33010725 [TBL] [Abstract][Full Text] [Related]
14. Tremor due to sodium valproate. Hyman NM; Dennis PD; Sinclair KG Neurology; 1979 Aug; 29(8):1177-80. PubMed ID: 379690 [TBL] [Abstract][Full Text] [Related]
16. Longitudinal study of clinical and neurophysiological features in essential tremor. Angelini L; Paparella G; De Biase A; Maraone A; Panfili M; Berardelli I; Cannavacciuolo A; Di Vita A; Margiotta R; Fabbrini G; Berardelli A; Bologna M Eur J Neurol; 2023 Mar; 30(3):631-640. PubMed ID: 36437695 [TBL] [Abstract][Full Text] [Related]
17. Disorders of Upper Limb Movements in Ataxia-Telangiectasia. Shaikh AG; Zee DS; Mandir AS; Lederman HM; Crawford TO PLoS One; 2013; 8(6):e67042. PubMed ID: 23826191 [TBL] [Abstract][Full Text] [Related]